Revisiting cardiovascular calcification: A multifaceted disease requiring a multidisciplinary approach

Seminars in Cell and Developmental Biology

Volumn 46, Issue , 2015, Pages 68-77

  Hutcheson, Joshua D ^a   Goettsch, Claudia ^a   Rogers, Maximillian A ^a   Aikawa, Elena ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aortic valve disease; Atherosclerosis; Cardiovascular calcification; Chronic renal disease; Microcalcification

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; COLLAGEN;

AORTA VALVE DISEASE; ARTERY CALCIFICATION; BIOMECHANICS; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL WALL; CARDIOVASCULAR CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR TISSUE; CEREBROVASCULAR ACCIDENT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; MINERALIZATION; NONHUMAN; PHENOTYPE; PHYSICAL CHEMISTRY; REVIEW; SOFT TISSUE CALCIFICATION; ANIMAL; AORTA VALVE; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL MODEL; CALCINOSIS; CORONARY ARTERY DISEASE; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; AORTIC VALVE; CALCINOSIS; CARDIOVASCULAR DISEASES; COLLAGEN; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; PLAQUE, ATHEROSCLEROTIC;

EID: 84952639267     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.09.004     Document Type: Review

References (119)

1. Vliegenthart R., et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 2005, 112(4):572-577.
2. Go A.S., et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014, 129(3):e28-e292.
3. Johnson R.C., Leopold J.A., Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ. Res. 2006, 99(10):1044-1059.
4. Sacks M.S., Yoganathan A.P. Heart valve function: a biomechanical perspective. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2007, 362(1484):1369-1391.
5. Wu M., Rementer C., Giachelli C.M. Vascular calcification: an update on mechanisms and challenges in treatment. Calcif. Tissue Int. 2013, 93(4):365-373.
6. Weinberg E.J., Schoen F.J., Mofrad M.R. A computational model of aging and calcification in the aortic heart valve. PLoS ONE 2009, 4(6):e5960.
7. Cardoso L., et al. Effect of tissue properties, shape and orientation of microcalcifications on vulnerable cap stability using different hyperelastic constitutive models. J. Biomech. 2014, 47(4):870-877.
8. Ruiz J.L., Hutcheson J.D., Aikawa E. Cardiovascular calcification: current controversies and novel concepts. Cardiovasc. Pathol. 2015.
9. Miller J.D., Weiss R.M., Heistad D.D. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ. Res. 2011, 108(11):1392-1412.
10. Ehara S., et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004, 110(22):3424-3429.
11. Criqui M.H., et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 2014, 311(3):271-278.
12. Kelly-Arnold A., et al. Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(26):10741-10746.
13. Maldonado N., et al. The explosive growth of small voids in vulnerable cap rupture; cavitation and interfacial debonding. J. Biomech. 2013, 46(2):396-401.
14. Maldonado N., et al. A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: potential implications for plaque rupture. Am. J. Physiol. Heart Circ. Physiol. 2012, 303(5):H619-H628.
15. Naghavi M., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003, 108(15):1772-1778.
16. Naghavi M., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108(14):1664-1672.
17. Holzapfel G.A., et al. Computational approaches for analyzing the mechanics of atherosclerotic plaques: a review. J. Biomech. 2014, 47(4):859-869.
18. Libby P. Collagenases and cracks in the plaque. J. Clin. Invest. 2013, 123(8):3201-3203.
19. Virmani R., et al. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 2006, 47(8 Suppl.):C13-C18.
20. Virmani R., et al. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J. Interv. Cardiol. 2003, 16(3):267-272.
21. Virmani R., et al. Vulnerable plaque: the pathology of unstable coronary lesions. J. Interv. Cardiol. 2002, 15(6):439-446.
22. Cheng G.C., et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 1993, 87(4):1179-1187.
23. Richardson P.D., Davies M.J., Born G.V. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989, 2(8669):941-944.
24. Cardoso L., Weinbaum S. Changing views of the biomechanics of vulnerable plaque rupture: a review. Ann. Biomed. Eng. 2014, 42(2):415-431.
25. Vengrenyuk Y., Cardoso L., Weinbaum S. Micro-CT based analysis of a new paradigm for vulnerable plaque rupture: cellular microcalcifications in fibrous caps. Mol. Cell. Biomech. 2008, 5(1):37-47.
26. Vengrenyuk Y., et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(40):14678-14683.
27. Rambhia S.H., et al. Microcalcifications increase coronary vulnerable plaque rupture potential: a patient-based micro-CT fluid-structure interaction study. Ann. Biomed. Eng. 2012, 40(7):1443-1454.
28. Otsuka F., et al. Has our understanding of calcification in human coronary atherosclerosis progressed?. Arterioscler. Thromb. Vasc. Biol. 2014, 34(4):724-736.
29. Lin T.C., et al. Mechanical response of a calcified plaque model to fluid shear force. Ann. Biomed. Eng. 2006, 34(10):1535-1541.
30. Imoto K., et al. Longitudinal structural determinants of atherosclerotic plaque vulnerability: a computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging. J. Am. Coll. Cardiol. 2005, 46(8):1507-1515.
31. Wong K.K., et al. Effect of calcification on the mechanical stability of plaque based on a three-dimensional carotid bifurcation model. BMC Cardiovasc. Disord. 2012, 12:7.
32. Gimbrone M.A., Garcia-Cardena G. Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis. Cardiovasc. Pathol. 2013, 22(1):9-15.
33. Hutcheson J.D., Aikawa E., Merryman W.D. Potential drug targets for calcific aortic valve disease. Nat. Rev. Cardiol. 2014, 11(4):218-231.
34. Goodman W.G., et al. Vascular calcification in chronic kidney disease. Am. J. Kidney Dis. 2004, 43(3):572-579.
35. Czarny M.J., Resar J.R. Diagnosis and management of valvular aortic stenosis. Clin. Med. Insights Cardiol. 2014, 8(Suppl. 1):15-24.
36. Aikawa E., et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007, 116(24):2841-2850.
37. Bach D.S. Prevalence and characteristics of unoperated patients with severe aortic stenosis. J. Heart Valve Dis. 2011, 20(3):284-291.
38. Aikawa E., Otto C.M. Look more closely at the valve: imaging calcific aortic valve disease. Circulation 2012, 125(1):9-11.
39. Guerraty M.A., et al. Relation of aortic valve calcium to chronic kidney disease (from the chronic renal insufficiency cohort study). Am. J. Cardiol. 2015, 115(9):1281-1286.
40. Rattazzi M., et al. Aortic valve calcification in chronic kidney disease. Nephrol. Dial. Transplant. 2013, 28(12):2968-2976.
41. Duer M.J., et al. Mineral surface in calcified plaque is like that of bone: further evidence for regulated mineralization. Arterioscler. Thromb. Vasc. Biol. 2008, 28(11):2030-2034.
42. Bertazzo S., et al. Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat. Mater. 2013, 12(6):576-583.
43. New S.E., et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ. Res. 2013, 113(1):72-77.
44. Kapustin A.N., et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ. Res. 2011, 109(1):e1-e12.
45. Anderson H.C. Matrix vesicles and calcification. Curr. Rheumatol. Rep. 2003, 5(3):222-226.
46. Anderson H.C., et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am. J. Pathol. 2004, 164(3):841-847.
47. Anderson H.C., Garimella R., Tague S.E. The role of matrix vesicles in growth plate development and biomineralization. Front. Biosci. 2005, 10:822-837.
48. Cmoch A., et al. Matrix vesicles isolated from mineralization-competent Saos-2 cells are selectively enriched with annexins and S100 proteins. Biochem. Biophys. Res. Commun. 2011, 412(4):683-687.
49. Mohler E.R., et al. Bone formation and inflammation in cardiac valves. Circulation 2001, 103(11):1522-1528.
50. Rajamannan N.M., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003, 107(17):2181-2184.
51. Zaheer A., et al. Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals. Arterioscler. Thromb. Vasc. Biol. 2006, 26(5):1132-1136.
52. Fleisch H. Development of bisphosphonates. Breast Cancer Res. 2002, 4(1):30-34.
53. Kozloff K.M., et al. Near-infrared fluorescent probe traces bisphosphonate delivery and retention in vivo. J. Bone Miner. Res. 2010, 25(8):1748-1758.
54. Rajamannan N.M., et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation 2011, 124(16):1783-1791.
55. New S.E., Aikawa E. Role of extracellular vesicles in de novo mineralization: an additional novel mechanism of cardiovascular calcification. Arterioscler. Thromb. Vasc. Biol. 2013, 33(8):1753-1758.
56. Demer L.L., Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler. Thromb. Vasc. Biol. 2014, 34(4):715-723.
57. Goettsch C., Hutcheson J.D., Aikawa E. MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms. Circ. Res. 2013, 112(7):1073-1084.
58. Paloian N.J., Giachelli C.M. A current understanding of vascular calcification in CKD. Am. J. Physiol. Renal Physiol. 2014, 307(8):F891-F900.
59. Leopold J.A. Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc. Med. 2014.
60. Negishi-Koga T., Takayanagi H. Bone cell communication factors and semaphorins. Bonekey Rep. 2012, 1:183.
61. Sun Y., et al. Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ. Res. 2012, 111(5):543-552.
62. Speer M.Y., et al. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J. Cell. Biochem. 2010, 110(4):935-947.
63. Doherty T.M., et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(20):11201-11206.
64. Demer L.L., Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008, 117(22):2938-2948.
65. Naik V., et al. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc. Res. 2012, 94(3):545-554.
66. Jono S., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 2000, 87(7):E10-E17.
67. Reynolds J.L., et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol. 2004, 15(11):2857-2867.
68. Shanahan C.M., et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ. Res. 2011, 109(6):697-711.
69. Shioi A., et al. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1995, 15(11):2003-2009.
70. Schack L.M., et al. The phosphate source influences gene expression and quality of mineralization during osteogenic differentiation of human mesenchymal stem cells. PLoS ONE 2013, 8(6):e65943.
71. Hutcheson J.D., et al. Enrichment of calcifying extracellular vesicles using density-based ultracentrifugation protocol. J. Extracell. Vesicles 2014, 3:25129.
72. Kapustin A.N., et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ. Res. 2015.
73. Alves R.D., et al. Calcifying vascular smooth muscle cells and osteoblasts: independent cell types exhibiting extracellular matrix and biomineralization-related mimicries. BMC Genomics 2014, 15:965.
74. Bujan J., et al. Modifications induced by atherogenic diet in the capacity of the arterial wall in rats to respond to surgical insult. Atherosclerosis 1996, 122(2):141-152.
75. Towler D.A., et al. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J. Biol. Chem. 1998, 273(46):30427-30434.
76. Yao Y., et al. A role for the endothelium in vascular calcification. Circ. Res. 2013, 113(5):495-504.
77. Bostrom K.I., Rajamannan N.M., Towler D.A. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ. Res. 2011, 109(5):564-577.
78. Wylie-Sears J., et al. Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler. Thromb. Vasc. Biol. 2011, 31(3):598-607.
79. Cheng S.L., et al. Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2013, 33(7):1679-1689.
80. Bowler M.A., Merryman W.D. In vitro models of aortic valve calcification: solidifying a system. Cardiovasc. Pathol. 2015, 24(1):1-10.
81. Rabkin E., et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001, 104(21):2525-2532.
82. Merryman W.D., et al. Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc. Pathol. 2007, 16(5):268-276.
83. Aikawa E., et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006, 113(10):1344-1352.
84. Monzack E.L., Masters K.S. Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. J. Heart Valve Dis. 2011, 20(4):449-463.
85. Yip C.Y., et al. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler. Thromb. Vasc. Biol. 2009, 29(6):936-942.
86. Benton J.A., et al. Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler. Thromb. Vasc. Biol. 2009, 29(11):1950-1957.
87. Hutcheson J.D., et al. Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts. Arterioscler. Thromb. Vasc. Biol. 2013, 33(1):114-120.
88. Hutcheson J.D., et al. Intracellular Ca(2+) accumulation is strain-dependent and correlates with apoptosis in aortic valve fibroblasts. J. Biomech. 2012, 45(5):888-894.
89. Chen J.H., Simmons C.A. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ. Res. 2011, 108(12):1510-1524.
90. Chen J., et al. Biophysical analysis of dystrophic and osteogenic models of valvular calcification. J. Biomech. Eng. 2015, 137(2):020903.
91. El Husseini D., et al. High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1. PLOS ONE 2013, 8(1):e53393.
92. Yutzey K.E., et al. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Arterioscler. Thromb. Vasc. Biol. 2014, 34(11):2387-2393.
93. Bairati A., DeBiasi S. Presence of a smooth muscle system in aortic valve leaflets. Anat. Embryol. (Berl.) 1981, 161(3):329-340.
94. Cimini M., Rogers K.A., Boughner D.R. Smoothelin-positive cells in human and porcine semilunar valves. Histochem. Cell Biol. 2003, 120(4):307-317.
95. Della Rocca F., et al. Cell composition of the human pulmonary valve: a comparative study with the aortic valve - the VESALIO Project. Vitalitate Exornatum Succedaneum Aorticum labore Ingegnoso Obtinebitur. Ann. Thorac. Surg. 2000, 70(5):1594-1600.
96. Latif N., et al. Expression of smooth muscle cell markers and co-activators in calcified aortic valves. Eur. Heart J. 2015, 36(21):1335-1345.
97. Tintut Y., et al. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000, 102(21):2636-2642.
98. Cote N., et al. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation 2013, 36(3):573-581.
99. Aikawa E., et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009, 119(13):1785-1794.
100. New S.E., Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ. Res. 2011, 108(11):1381-1391.
101. Byon C.H., et al. Runx2-upregulated receptor activator of nuclear factor kappaB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler. Thromb. Vasc. Biol. 2011, 31(6):1387-1396.
102. Fadini G.P., et al. Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation 2012, 125(22):2772-2781.
103. Gossl M., et al. Role of circulating osteogenic progenitor cells in calcific aortic stenosis. J. Am. Coll. Cardiol. 2012, 60(19):1945-1953.
104. Fadini G.P., et al. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ. Res. 2011, 108(9):1112-1121.
105. Collin J., et al. Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis. Int. J. Cardiol. 2014, 181C:57-64.
106. Helske S., et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur. Heart J. 2006, 27(12):1495-1504.
107. Helske S., et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J. Am. Coll. Cardiol. 2004, 44(9):1859-1866.
108. Wypasek E., et al. Mast cells in human stenotic aortic valves are associated with the severity of stenosis. Inflammation 2013, 36(2):449-456.
109. Hergenreider E., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 2012, 14(3):249-256.
110. Chen M.B., et al. A 3D microfluidic platform incorporating methacrylated gelatin hydrogels to study physiological cardiovascular cell-cell interactions. Lab Chip 2013, 13(13):2591-2598.
111. Hjortnaes J., et al. Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform. Adv. Healthc. Mater. 2014.
112. Butcher J.T., Nerem R.M. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng. 2006, 12(4):905-915.
113. Dahan N., et al. Porcine small diameter arterial extracellular matrix supports endothelium formation and media remodeling forming a promising vascular engineered biograft. Tissue Eng. Part A 2012, 18(3-4):411-422.
114. Battiston K.G., et al. Monocyte/macrophage cytokine activity regulates vascular smooth muscle cell function within a degradable polyurethane scaffold. Acta Biomater. 2014, 10(3):1146-1155.
115. Zuniga M.C., White S.L., Zhou W. Design and utilization of macrophage and vascular smooth muscle cell co-culture systems in atherosclerotic cardiovascular disease investigation. Vasc. Med. 2014, 19(5):394-406.
116. Steitz S.A., et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ. Res. 2001, 89(12):1147-1154.
117. Proudfoot D., et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 2000, 87(11):1055-1062.
118. Itou T., et al. Cystathionine gamma-lyase accelerates osteoclast differentiation: identification of a novel regulator of osteoclastogenesis by proteomic analysis. Arterioscler. Thromb. Vasc. Biol. 2014, 34(3):626-634.
119. Hjortnaes J., et al. Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis 2015, 242(1):251-260.